Tag - IBIO

Developments

iBio inks 3D bioprinting agreement with United Therapeutics’ subsidiary, Lung Biotechnology PBC

iBio (NYSE AMERICAN:IBIO) entered into an agreement with Lung Biotechnology, a subsidiary of United Therapeutics (NASDAQ:UTHR), to produce recombinant human collagen (rhCollagen)-based bioink for 3D bioprinted organ...

August 19, 2019

Executive Moves

iBio names industry veteran Thomas Isett to board

iBio (NYSE AMERICAN:IBIO) appointed Thomas Isett as a director, effective immediately.

April 1, 2019

Feature

iBio spearheading plant-based biopharmaceuticals at CDMO plant

By Len Zehr iBio (NYSE American:IBIO) has developed an industry-leading plant-based gene-expression technology to rapidly produce high levels of proteins used for making biologics at its contract development and...

December 18, 2018

Tag - IBIO

iBio inks 3D bioprinting agreement with United Therapeutics’ subsidiary, Lung Biotechnology PBC

iBio names industry veteran Thomas Isett to board

iBio spearheading plant-based biopharmaceuticals at CDMO plant

General

More